This is a $15,905,698.25 definitive contract awarded to Wayne State University by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract is for enhancing U.S. surveillance of laboratory confirmed SARS-CoV-2, influenza, and other respiratory viruses. It does not have a set-aside designation. The contract includes multiple subcontractors, including the University of California, San Francisco, Intermountain Healthcare, Icahn School of Medicine at Mount Sinai, and others, to...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $49,995,944 definitive cost-no-fee contract to Vanderbilt University Medical Center for Surveillance of Acutely Ill Adults with Respiratory Viruses, Including SARS-CoV-2. Vanderbilt University Medical Center will serve as the prime contractor and has subcontracted portions of the work to 26 other institutions, including The Cleveland Clinic Foundation, University of Utah, Beth Israel Deaconess...
This definitive contract from the Department of Health and Human Services Centers for Disease Control and Prevention (HHS-CDC) awards $1,595,336 to The Regents of the University of California, San Francisco (UCSF) as the prime contractor to conduct a clinical study examining the effects of N95 respirator extended use and reuse in healthcare settings. Major subcontractors include The Johns Hopkins University, Emory University, the University of Wisconsin-Madison, and the University of...
This is a $13,460,835.60 delivery order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Vanderbilt University Medical Center. The contract is for an Adult Inpatient and Outpatient VE Case Control Study, which will evaluate the effectiveness of COVID-19 and influenza vaccines. This order falls under the larger Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) indefinite delivery/indefinite quantity...
This firm fixed price contract from the Centers for Disease Control and Prevention (CDC) to Vanderbilt University Medical Center (VUMC) evaluates the effectiveness of vaccines against COVID-19, influenza, and respiratory syncytial virus (RSV) among U.S. adults with severe acute respiratory illness. The $11,908,903.84 potential value contract monitors effectiveness against COVID-19, influenza, and emerging variants, as well as duration of protection. It also conducts RSV surveillance and builds...
This is a Cost Plus Fixed Fee contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company, for a prospective, natural history study of SARS-CoV-2 infection in Wake Forest healthcare workers. The $54,179,237.36 contract was awarded on July 1, 2020 with a period of performance through February 28, 2023. The original solicitation was Broad Agency Announcement number 75D301-20-R-67897, which sought white papers from...
This is a $847,345.00 firm fixed price federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Yale University, a private non-profit research university, to conduct research on virus genomics and human mobility patterns related to the spread of SARS-CoV-2. The contract has a completion date of September 20, 2022 and was originally awarded on September 22, 2020. As part of this contract, Yale University has issued a subcontract to...
This is a $4,916,756.12 firm fixed price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Utah Office of Sponsored Projects. The contract is for "2021 DOMAIN 1-A015 MODELING AND NOVEL DATA" work under the CDC's Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) multi-award indefinite delivery/indefinite quantity (IDIQ) contract. The contract has an ultimate completion date of August 31,...
This is a $89,948,062 cost-plus-fixed-fee contract awarded by the Centers for Disease Control and Prevention (CDC) to ABT Global LLC, a subsidiary of ABT Associates Inc., for COVID-19 research in response to a Broad Agency Announcement posting. The contract does not have a set-aside designation. The research aims to evaluate the effectiveness of COVID-19 vaccines among essential workers through a project called "Research on the Epidemiology of SARS-CoV-2 in Essential Response...
The Centers for Disease Control and Prevention awarded a $999,918.64 delivery order contract to the National Academy of Sciences to provide technical support services for health and scientific research studies related to the Coronavirus COVID-19 pandemic. The contract is being carried out under an indefinite-delivery, indefinite-quantity vehicle and calls for the prime contractor, the National Academy of Sciences, to support the CDC's coronavirus response efforts through July 2023. No...